Genitourinary Cancer Epidemiology Group
The Genitourinary Cancer Epidemiology Group is a dynamic group of students, researchers, faculty, and staff led by Dr. Lorelei Mucci. We investigate research questions focused on cancer etiology, mortality, and survivorship, particularly among individuals with prostate cancer and other genitourinary cancers.
Email
lmucci@hsph.harvard.edu
Phone
617-432-1732
Follow
Location
677 Huntington Ave,
Kresge Building, Office 920E
Boston, MA 02115
Selected Publications
- What’s in a Name? Why Words Matter in Advanced Prostate Cancer. Oh WK, Agarwal N, Bryce A, Barata P, Bugler C, Carlsson SV, Cornell B, Dahut W, George D, Loeb S, Montgomery B, Morris D, Mucci LA, Omlin A, Palapattu G, Riaz IB, Ryan C, Schoen MW, Washington SL 3rd, Gillessen S. Eur Urol. 2024 Oct 28:S0302-2838(24)02680-0. doi: 10.1016/j.eururo.2024.10.017. Epub ahead of print. PMID: 39472202.
- Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer. Stopsack KH, Vijai J, Conry M, Berchuck JE, Kemel Y, Vasselman SE, Freeman DA, Lee GM, Mandelker D, Solit DB, Morris MJ, Penney KL, Abida W, Offit K, Mucci LA, Kantoff PW, Pomerantz MM. Clin Cancer Res. 2024 Oct 25. doi: 10.1158/1078-0432.CCR-24-2483. Epub ahead of print. PMID: 39450704.
- RAD21 promotes oncogenesis and lethal progression of prostate cancer. Su XA, Stopsack KH, Schmidt DR, Ma D, Li Z, Scheet PA, Penney KL, Lotan TL, Abida W, DeArment EG, Lu K, Janas T, Hu S, Vander Heiden MG, Loda M, Boselli M, Amon A, Mucci LA. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2405543121. doi: 10.1073/pnas.2405543121. Epub 2024 Aug 27. PMID: 39190349; PMCID: PMC11388324.
- Neighborhood greenness and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study. Chen N, Hu CR, Iyer HS, James P, Dickerman BA, Mucci LA, Nethery RC. Environ Res. 2024 Aug 24;262(Pt 1):119847. doi: 10.1016/j.envres.2024.119847. Epub ahead of print. PMID: 39187150.
- Incidence of de novo malignancy and all-cause mortality among heart transplant recipients. Barrera FJ, Mostofsky E, Salia S, Lehman L, Liou L, Mucci L, Mittleman MA. Int J Cardiol. 2024 Nov 15;415:132455. doi: 10.1016/j.ijcard.2024.132455. Epub 2024 Aug 15. PMID: 39153512; PMCID: PMC11426084.
- Intratumoral vitamin D signaling and lethal prostate cancer. Vaselkiv JB, Shui IM, Grob ST, Ericsson CI, Giovannucci I, Peng C, Finn SP, Mucci LA, Penney KL, Stopsack KH. Carcinogenesis. 2024 Oct 10;45(10):735-744. doi: 10.1093/carcin/bgae055. PMID: 39120256; PMCID: PMC11464699.
- All-cause and cause-specific mortality risk and loss in life expectancy associated with incident type 2 diabetes onset age and duration. Zhang Y, Song M, Wang M, Hertzmark E, Wu K, Eliassen AH, Mucci LA, Sun Q, Stampfer MJ, Willett WC, Hu FB, Giovannucci EL. J Intern Med. 2024 Sep;296(3):260-279. doi: 10.1111/joim.13817. Epub 2024 Jul 18. PMID: 39021307.
- Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the Health Professionals Follow-up Study. Guo F, McGee EE, Chiu YH, Giovannucci E, Mucci LA, Dickerman BA. Am J Epidemiol. 2024 Jul 5:kwae184. doi: 10.1093/aje/kwae184. Epub ahead of print. PMID: 38973750.
- Coffee, Phosphoinositide 3-Kinase Signaling Pathway, and Prostate Cancer: A Prospective Study in the Health Professionals Follow-Up Study. Song R, Stopsack KH, Ren J, Mucci LA, Clinton SK, Loda M, Wang M, Giovannucci EL, Wilson KM, Smith-Warner SA. J Acad Nutr Diet. 2024 Jul 4:S2212-2672(24)00537-9. doi: 10.1016/j.jand.2024.07.001. Epub ahead of print. PMID: 38971221.
- Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk. Plym A, Zhang Y, Stopsack KH, Ugalde-Morales E, Seibert TM, Conti DV, Haiman CA, Baras A, Stocks T, Drake I, Penney KL, Giovannucci E, Kibel AS, Wiklund F, Mucci LA; Regeneron Genetics Center. JAMA Netw Open. 2024 Jul 1;7(7):e2420034. doi: 10.1001/jamanetworkopen.2024.20034. PMID: 38958976; PMCID: PMC11222990.
- Social integration and long-term physical and psychosocial quality of life among prostate cancer survivors in the Health Professionals Follow-up Study. Chen N, McGrath CB, Stopsack KH, Morgans AK, Nethery RC, Dickerman BA, Mucci LA. J Cancer Surviv. 2024 Jul 1. doi: 10.1007/s11764-024-01632-0. Epub ahead of print. PMID: 38951371.
- Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer. Rumpf F, Plym A, Vaselkiv JB, Penney KL, Preston MA, Kibel AS, Mucci LA, Salari K. J Urol. 2024 Jun;211(6):754-764. doi: 10.1097/JU.0000000000003927. Epub 2024 Apr 10. PMID: 38598641; PMCID: PMC11251859.
- Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer. Zhang Y, Stopsack KH, Wu K, Song M, Mucci LA, Giovannucci E. Br J Cancer. 2024 Jun;130(10):1709-1715. doi: 10.1038/s41416-024-02651-5. Epub 2024 Mar 15. PMID: 38491175; PMCID: PMC11091183.
- Combining magnetic resonance imaging with a multi-ancestry polygenic risk score to improve identification of clinically significant prostate cancer. Plym A, Madueke I, Naik S, Isabelle M, Conti DV, Haiman CA, Penney KL, Mucci LA, Khorasani R, Kibel AS. JNCI Cancer Spectr. 2024 Feb 29;8(2):pkae014. doi: 10.1093/jncics/pkae014. PMID: 38429995; PMCID: PMC10980589.
- Healthy dietary patterns and risk of prostate cancer in men at high genetic risk. Zhang Y, Stopsack KH, Song M, Mucci LA, Liu B, Penney KL, Tabung FK, Giovannucci E, Plym A. Int J Cancer. 2024 Jul 1;155(1):71-80. doi: 10.1002/ijc.34898. Epub 2024 Mar 1. PMID: 38429859; PMCID: PMC11068494.
- A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Liu Q, Zhang Y, Vaselkiv JB, Mucci LA, Giovannucci EL, Platz EA, Sutcliffe S. Br J Cancer. 2024 May;130(8):1295-1303. doi: 10.1038/s41416-024-02593-y. Epub 2024 Feb 22. PMID: 38388857; PMCID: PMC11015033.
- Plant-based diet associated with better quality of life in prostate cancer survivors. Loeb S, Hua Q, Bauer SR, Kenfield SA, Morgans AK, Chan JM, Van Blarigan EL, Shreves AH, Mucci LA. Cancer. 2024 Feb 13. doi: 10.1002/cncr.35172. Online ahead of print. PMID: 38348508
- Adiposity, Weight Change, and Urinary Melatonin Levels among Men in the Multiethnic Cohort. Chowdhury-Paulino IM, Vaselkiv JB, Cheng I, Schernhammer ES, Lin Z, Haiman CA, Le Marchand L, Valdimarsdóttir U, Wilkens LR, Markt SC, Mucci LA. Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):136-142. doi: 10.1158/1055-9965.EPI-23-0860. PMID: 37909946
- Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer. Chen N, McGrath CB, Ericsson CI, Vaselkiv JB, Rencsok EM, Stopsack KH, Guard HE, Autio KA, Rathkopf DE, Enting D, Bitting RL, Mateo J, Githiaka CW, Chi KN, Cheng HH, Davis ID, Anderson SG, Badal SAM, Bjartell A, Russnes KM, Heath EI, Pomerantz MM, Henegan JC, Hyslop T, Esteban E, Omlin A, McDermott R, Fay AP, Popoola AA, Ragin C, Nowak J, Gerke T, Kantoff PW, George DJ, Penney KL, Mucci LA; IRONMAN Registry. Cancer Epidemiol Biomarkers Prev. 2024 Mar 1;33(3):419-425. doi: 10.1158/1055-9965.EPI-23-1207. PMID: 38189661
- Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States. Rencsok EM, Slopen N, McManus HD, Autio KA, Morgans AK, McSwain L, Barata P, Cheng HH, Dreicer R, Gerke T, Green R, Heath EI, Howard LE, McKay RR, Nowak J, Pileggi S, Pomerantz MM, Rathkopf DE, Tagawa ST, Whang YE, Ragin C, Odedina FT, Kantoff PW, Vinson J, Villanti P, Haneuse S, Mucci LA, George DJ; IRONMAN Registry. Cancer Res Commun. 2024 Jan 8;4(1):55-64. doi: 10.1158/2767-9764.CRC-23-0446. PMID: 38108490; PMCID: PMC10773321.
- Adiposity, Weight Change, and Urinary Melatonin Levels among Men in the Multiethnic Cohort. Chowdhury-Paulino IM, Vaselkiv JB, Cheng I, Schernhammer ES, Lin Z, Haiman CA, Le Marchand L, Valdimarsdóttir U, Wilkens LR, Markt SC, Mucci LA. Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):136-142. doi: 10.1158/1055-9965.EPI-23-0860. PMID: 37909946.
- SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Rajanala SH, Plym A, Vaselkiv JB, Ebot EM, Matsoukas K, Lin Z, Chakraborty G, Markt SC, Penney KL, Lee GM, Mucci LA, Kantoff PW, Stopsack KH. Carcinogenesis. 2024 Feb 12;45(1-2):35-44. doi: 10.1093/carcin/bgad075. PMID: 37856781; PMCID: PMC10859730.
- Promoting Reproducibility and Integrity in Observational Research: One APproach of an Epidemiology Research Community. Stopsack KH, Mucci LA, Tworoger SS, Kang JH, Eliassen AH, Willett WC, Stampfer MJ. 2023 May 1;34(3):389-395. doi: 10.1097/EDE.0000000000001599. Epub 2023 Jan 31. PMID: 36719725; PMCID: PMC10073307.
- Relationship between cigarette use and prostate cancer risk: what do we know and what should we do? Nolazco JI, Mucci LA, Sosnowski R, Przewoźniak K, Chang SL, De Nunzio C. Prostate Cancer Prostatic Dis. 2023 Apr 22. doi: 10.1038/s41391-023-00671-5. Epub ahead of print. PMID: 37087528.
- Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Stopsack KH, Su XA, Vaselkiv JB, Graff RE, Ebot EM, Pettersson A, Lis RT, Fiorentino M, Loda M, Penney KL, Lotan TL, Mucci LA.Mol Cancer Res. 2023 Jan 3;21(1):14-23. doi: 10.1158/1541-7786.MCR-22-0446.PMID: 3612551.
- The Imperative for Population-based Cancer Registration of All Metastatic Cancers.Stopsack KH, Plym A, Mucci LA.Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):585-587. doi: 10.1158/1055-9965.EPI-23-0115.PMID: 37125486
- Aggressive Prostate Cancer Is Preventable and so Are Racial Disparities. Stopsack KH, Mucci LA, Giovannucci EL.J Clin Oncol. 2023 Jul 10:JCO2300507. doi: 10.1200/JCO.23.00507. Online ahead of print.PMID: 37428996
- Experience with the US health care system for Black and White patients with advanced prostate cancer. Rencsok EM, Stopsack KH, Slopen N, Odedina FT, Ragin C, Nowak J, McSwain L, Manarite J, Heath E, George DJ, Kantoff PW, Vinson J, Villanti P, Haneuse S, Mucci LA; IRONMAN Registry.Cancer. 2023 Aug 15;129(16):2532-2541. doi: 10.1002/cncr.34885. Epub 2023 May 28.PMID: 37246339
- Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US. Rencsok EM, Slopen N, Autio K, Morgans A, McSwain L, Barata P, Cheng HH, Dreicer R, Heath E, McKay RR, Pomerantz M, Rathkopf D, Tagawa S, Whang YE, Ragin C, Odedina FT, George DJ, Kantoff PW, Vinson J, Villanti P, Haneuse S, Mucci LA; IRONMAN Registry.Qual Life Res. 2023 Jul 6. doi: 10.1007/s11136-023-03468-0. Online ahead of print.PMID: 37410340
- A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer. Plym A, Zhang Y, Stopsack KH, Delcoigne B, Wiklund F, Haiman C, Kenfield SA, Kibel AS, Giovannucci E, Penney KL, Mucci LA. Eur Urol. 2023 Apr;83(4):343-351. doi: 10.1016/j.eururo.2022.05.008. Epub 2022 May 28. PMID: 35637041; PMCID: PMC10279925.
- Adiposity, weight change, and urinary melatonin levels among men in the Multiethnic Cohort. Chowdhury-Paulino IM, Vaselkiv JB, Cheng I, Schernhammer ES, Lin Z, Haiman CA, Le Marchand L, Valdimarsdóttir U, Wilkens LR, Markt SC, Mucci LA. Cancer Epidemiol Biomarkers Prev. 2023 Nov 1. doi: 10.1158/1055-9965.EPI-23-0860. Epub ahead of print. PMID: 37909946.
- Loeb S, Fu BC, Bauer SR, Pernar CH, Chan JM, Van Blarigan EL, Giovannucci EL, Kenfield SA, Mucci LA. Association of plant-based diet index with prostate cancer risk. Am J Clin Nutr. 2022 Mar 4;115(3):662-670.
- Chowdhury-Paulino IM, Ericsson C, Vince R Jr, Spratt DE, George DJ, Mucci LA. Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):397-402.
- Plym A, Zhang Y, Stopsack KH, Delcoigne B, Wiklund F, Haiman C, Kenfield SA, Kibel AS, Giovannucci E, Penney KL, Mucci LA. A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer. Eur Urol. 2022 May 27:S0302-2838(22)02342-9.
- Hansen M, Hamieh NM, Markt SC, Vaselkiv JB, Pernar CH, Gonzalez-Feliciano AG, Peisch S, Chowdhury-Paulino IM, Rencsok EM, Rebbeck TR, Platz EA, Giovannucci EL, Wilson KM, Mucci LA. Racial Disparities in Prostate Cancer: Evaluation of Diet, Lifestyle, Family History, and Screening Patterns. Cancer Epidemiol Biomarkers Prev. 2022 May 4;31(5):982-990.
- Vaselkiv JB, Ceraolo C, Wilson KM, Pernar CH, Rencsok EM, Stopsack KH, Grob ST, Plym A, Giovannucci EL, Olumi AF, Kibel AS, Preston MA, Mucci LA. 5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1460-1465.
- IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer.Mucci LA, Vinson J, Gold T, Gerke T, Filipenko J, Green RM, Anderson SG, Badal S, Bjartell A, Chi KN, Davis ID, Enting D, Fay AP, Lazarus J, Mateo J, McDermott R, Odedina FT, Olmos D, Omlin A, Popoola AA, Ragin C, Roberts R, Russnes KM, Waihenya C, Stopsack KH, Hyslop T, Villanti P, Kantoff PW, George DJ; IRONMAN Global Team.JCO Glob Oncol. 2022 Nov;8:e2200154. doi: 10.1200/GO.22.00154.PMID: 36332173
- Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.Plym A, Zhang Y, Stopsack KH, Jee YH, Wiklund F, Kibel AS, Kraft P, Giovannucci E, Penney KL, Mucci LA.Clin Cancer Res. 2022 Nov 14;28(22):4926-4933. doi: 10.1158/1078-0432.CCR-22-1723.PMID: 36103261
- Minhaj Siddiqui M, Giovannucci EL, Mucci LA. Can there be consensus on whether vasectomy is a prostate cancer risk factor? Prostate Cancer Prostatic Dis. 2021 Dec;24(4):939-941.
- Fu BC, Tabung FK, Pernar CH, Wang W, Gonzalez-Feliciano AG, Chowdhury-Paulino IM, Clinton SK, Folefac E, Song M, Kibel AS, Giovannucci EL, Mucci LA. Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer. Eur Urol. 2021 Mar;79(3):405-412.
- Fu BC, Chowdhury-Paulino IM, Giovannucci EL, Mucci LA. Prenatal and Perinatal Factors and Risk of Cancer in Middle and Older Adulthood among Men. Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1841-1845.
- Pernar CH, Parmigiani G, Giovannucci EL, Rimm EB, Tyekucheva S, Loda M, Finn SP, Vander Heiden MG, Fiorentino M, Ebot EM, Mucci LA. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):751-756.
- Feng X, Zhou CK, Clish CB, Wilson KM, Pernar CH, Dickerman BA, Loda M, Finn SP, Penney KL, Schmidt DR, Vander Heiden MG, Giovannucci EL, Ebot EM, Mucci LA. Association of Prediagnostic Blood Metabolomics with Prostate Cancer Defined by ERG or PTEN Molecular Subtypes. Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):1000-1008.
- Stopsack KH, Tyekucheva S, Wang M, Gerke TA, Vaselkiv JB, Penney KL, Kantoff PW, Finn SP, Fiorentino M, Loda M, Lotan TL, Parmigiani G, Mucci LA. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays. Elife. 2021 Dec 23;10:e71265.
- McKay RR, Gold T, Zarif JC, Chowdhury-Paulino IM, Friedant A, Gerke T, Grant M, Hawthorne K, Heath E, Huang FW, Jackson MD, Mahal B, Ogbeide O, Paich K, Ragin C, Rencsok EM, Simmons S, Yates C, Vinson J, Kantoff PW, George DJ, Mucci LA. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry. JCO Glob Oncol. 2021 Apr;7:495-505.
- Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?Cancer Discov. 2020 Apr 10.
- Fu BC, Song M, Li X, Han J, Adami HO, Giovannucci EL, Mucci LA. Height as a mediator of sex differences in cancer risk.Ann Oncol. 2020 May;31(5):634-640.
- Dickerman BA & Mucci LA. Obesity, heigh, and advanced prostate cancer: extending current evidence toward precision prevention. Ann Oncol. 2020 Jan 31; (1) 7-8.
- Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, Stampfer MJ, Giovannucci E, Sweeney CJ, Finn SP, Mucci LA. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clin Cancer Res. 2019 Nov 21. [Epub ahead of print]
- Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M, Elfandy H, Syamala S, Karoly ED, Alshalalfa M, Erho N, Ross A, Schaeffer EM, Gibb EA, Takhar M, Den RB, Lehrer J, Karnes RJ, Freedland SJ, Davicioni E, Spratt DE, Ellis L, Jaffe JD, DʼAmico AV, Kantoff PW, Bradner JE, Mucci LA, Chavarro JE, Loda M, Brown M. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. Nat Commun. 2019 Sep 25;10(1):4358.
- Pernar CH, Ebot EM, Pettersson A, Graff RE, Giunchi F, Ahearn TU, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Stopsack KH, Gazeeva E, Lis RT, Parmigiani G, Rimm EB, Finn SP, Giovannucci EL, Fiorentino M, Mucci LA. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG. Eur Urol. 2018 Oct 6. pii: S0302- 2838(18)30730-9. [Epub ahead of print]
- Barber LE, Gerke T, Markt SC, Peisch SF, Wilson KM, Ahearn TU, Giovannucci EL, Parmigiani G, Mucci LA. Family history of breast or prostate cancer and prostate cancer risk. Clin Cancer Res. 2018 Aug 6. [Epub ahead of print]
- Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ. Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study. Eur Urol Oncol. 2019;2(2):126-134. Epub 2018 Jul 31.
- Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA**, Wilson KM**. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men. Eur Urol. 2018 [Epub ahead of print] ** Shared last authorship.
- Markt SC, Nuttall E, Turman C, Sinnott J, Rimm EB, Ecsedy E, Unger RH, Fall K, Finn S, Jensen MK, Rider JR, Kraft P, Mucci LA. Sniffing out significant “Pee values”: genome wide association study of asparagus anosmia. BMJ. 2016 Dec 13;355:i6071. PMCID: PMC5154975.
- Mehra R, Udager AM, Ahearn TU, Cao X, Feng FY, Loda M, Petimar JS, Kantoff P, Mucci LA**, Chinnaiyan AM**. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer. Eur Urol. 2016 Oct;70(4):549-552. PMCID: PMC4919276.
- Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH, McIntosh C, Nuttall E, Brandt I, Penney KL, Hartman M, Kraft P, Parmigiani G, Christensen K, Koskenvuo M, Holm NV, Heikkilä K, Pukkala E, Skytthe A, Adami HO, Kaprio J; Nordic Twin Study of Cancer (NorTwinCan) Collaboration. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. JAMA. 2016 Jan 5;315(1):68-76.
- Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016; 34: 2705-11. PMCID: PMC5019757.
- Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA**, Lotan TL**. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2015 Nov 27;108(2). PMCID: PMC4862436. **Shared last authorship
- Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Urinary Melatonin Levels, Sleep Disruption, and Risk of Prostate Cancer in Elderly Men. Eur Urol. 2015 Feb;67(2):191-4. PMCID: PMC4318783.